Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of the Use of Blood Biomarkers for the Diagnosis and Monitoring of Alzheimer's Disease

NCT05427448 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05427448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05427448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of the Use of Blood Biomarkers for the Diagnosis and Monitoring of Alzheimer's Disease
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
November 24, 2022
Completion date
May 20, 2025
Enrollment
342 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, mild cognitive impairment, tauopathies